Complement activation and prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.

Complement activation and prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.

Item
http://www.wikidata.org/entity/Q35841134
Glycation of the complement regulatory protein CD59 is a novel biomarker for glucose handling in humansRole of complement and complement regulatory proteins in the complications of diabetesA specific and sensitive assay for blood levels of glycated CD59: a novel biomarker for diabetes.Association between endogenous complement inhibitor and myocardial salvage in patients with myocardial infarction.Hematology and diabetes: from hemoglobin A1c to CD59 glycation.Molecular biology of atherosclerosis.The role of complement system in adipose tissue-related inflammation.Elevated Serum Mannose-Binding Lectin Levels Are Associated with Poor Outcome After Acute Ischemic Stroke in Patients with Type 2 Diabetes.Glycemic Control in Coronary Revascularization.Hemoglobin A1c is associated with severity of coronary artery stenosis but not with long term clinical outcomes in diabetic and nondiabetic patients with acute myocardial infarction undergoing primary angioplastyIncreased complements and high-sensitivity C-reactive protein predict heart failure in acute myocardial infarction.Downregulation of the Complement Cascade In Vitro, in Mice and in Patients with Cardiovascular Disease by the BET Protein Inhibitor Apabetalone (RVX-208).Plasma levels of mannan-binding lectin (MBL)-associated serine proteases (MASPs) and MBL-associated protein in cardio- and cerebrovascular diseases.A distinctive histidine residue is essential for in vivo glycation-inactivation of human CD59 transgenically expressed in mice erythrocytes: Implications for human diabetes complications.A model to study complement involvement in experimental retinal degeneration.Deficiency of the complement regulatory protein CD59 accelerates the development of diabetes-induced atherosclerosis in mice.New insight into the role of the complement in the most common types of retinopathy-current literature review
P2860

Complement activation and prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.

Item
http://www.wikidata.org/entity/Q35841134
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Complement activation and prog ...... eport from the DIGAMI 2 trial.
@ast
Complement activation and prog ...... eport from the DIGAMI 2 trial.
@en
type
label
Complement activation and prog ...... eport from the DIGAMI 2 trial.
@ast
Complement activation and prog ...... eport from the DIGAMI 2 trial.
@en
prefLabel
Complement activation and prog ...... eport from the DIGAMI 2 trial.
@ast
Complement activation and prog ...... eport from the DIGAMI 2 trial.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Complement activation and prog ...... report from the DIGAMI 2 trial
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932